5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)

NCT05577845 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

212

Enrollment

OTHER

Sponsor class

Conditions

LARS - Low Anterior Resection Syndrome

Interventions

DRUG: Ramosetron

Sponsor

Seoul National University Hospital